MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 219 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 4.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,466,000 | -22.3% | 46,500 | -25.0% | 0.25% | -22.2% |
| Q2 2022 | $1,886,000 | -31.9% | 62,000 | -56.9% | 0.32% | -46.8% |
| Q3 2021 | $2,771,000 | -13.2% | 144,000 | 0.0% | 0.61% | -7.7% |
| Q2 2021 | $3,194,000 | -15.5% | 144,000 | 0.0% | 0.66% | -14.9% |
| Q1 2021 | $3,780,000 | +58.0% | 144,000 | +12.5% | 0.78% | +24.1% |
| Q4 2020 | $2,392,000 | +176.2% | 128,000 | +151.0% | 0.63% | +173.8% |
| Q3 2020 | $866,000 | +551.1% | 51,000 | +580.0% | 0.23% | +1981.8% |
| Q3 2014 | $133,000 | -14.2% | 7,500 | 0.0% | 0.01% | -8.3% |
| Q2 2014 | $155,000 | -52.6% | 7,500 | -50.0% | 0.01% | -52.0% |
| Q1 2014 | $327,000 | +23.4% | 15,000 | +50.0% | 0.02% | +31.6% |
| Q4 2013 | $265,000 | -10.5% | 10,000 | -20.0% | 0.02% | +18.8% |
| Q3 2013 | $296,000 | +10.0% | 12,500 | 0.0% | 0.02% | +33.3% |
| Q2 2013 | $269,000 | – | 12,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |